Disease | polyneuropathy |
Phenotype | C0011849|diabetes mellitus |
Sentences | 9 |
PubMedID- 23834220 | The disruption of paranodal axo-glial junctions was found in sural nerve biopsy specimens from patients with polyneuropathy associated with type 1 diabetes mellitus, a disease caused by the autoimmune destruction of pancreatic islet cells and loss of insulin production (sima et al., 1988). |
PubMedID- 21350421 | [efficiency of cerebrolysin in the diabetic polyneuropathy in patients with insulin-dependency diabetes mellitus]. |
PubMedID- 24893232 | The evidence from clinical trials shows that intensive glycemic control reduces prevalence of diabetic sensorimotor polyneuropathy in patients with type 1 diabetes mellitus, but variable outcomes are observed in patients with type 2 diabetes mellitus. |
PubMedID- 22678671 | [distal polyneuropathy in children with diabetes mellitus type 1]. |
PubMedID- 22613432 | Objectives: to determine among adult patients with type-2 diabetes mellitus the proportion diagnosed with diabetic polyneuropathy (dpn) by clinical evaluation and by the hoffmann reflex (h-reflex). |
PubMedID- 24174953 | Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus. |
PubMedID- 20571999 | These are the hallmarks of distal-symmetric sensory polyneuropathy (pnp), with diabetes mellitus being the most common cause in our patient population. |
PubMedID- 24639928 | Diabetic polyneuropathy (dpn) in patients with diabetes mellitus is a heterogeneous disease that involves various parts of the nervous system thus producing a variety of clinical symptoms. |
PubMedID- 22457690 | Concomitant history included pharmacologically controlled hypertension, type 2 diabetes mellitus with polyneuropathy, hypercholesterolaemia, peripheral artery disease, depression and benign prostatic hypertrophy. |
Page: 1